chromium(3+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
chromium(3+) — decreases C-reactive protein concentration
Evidence strength: very limited.Findingreplicated ×3“Taking chromium led to a significant reduction in hirsutism (-1.8 ± 2.5 vs. -0.2 ± 0.8, P = 0.002), serum high-sensitivity C-reactive protein (hs-CRP) (-717.0 ± 1496.1 vs. +227.1 ± 1669.6 ng/mL, P = 0.02), plasma malondialdehyde (MDA) (-0.1 ± 0.7 vs. +1.1 ± 1.5 μmol/L, P < 0.001), and a significant increase in plasma total antioxidant capacity (TAC) concentrations (+250.7 ± 265.2 vs. +13.0 ± 201.6 mmol/L, P < 0.001).”
Quoted verbatim from The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 μg chromium daily for 8 weeks
- Population
- Women with polycystic ovary syndrome randomised to 200 μg chromium daily or placebo
The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.2016PMID:2661379010.1007/s12011-015-0570-6Permalink
To cite this finding: https://catalystproject.ai/e/01M5MF8YXBQ0NR2DJM02NQ03XN